Crystalys Therapeutics
Updated: July 31, 2026
CEO - James Mackay
Country: USA | Funding: $335M (+)
Founded: 2025
Website: https://crystalystx.com
Its gout drug Dotinurad is a once-daily oral inhibitor of urate transporter 1, designed to help the kidneys excrete uric acid. Excess uric acid can lead to the formation of crystals in the joints, causing the painful inflammation associated with gout. The drug's molecule is already approved in several Asian markets.
Founded: 2025
Website: https://crystalystx.com
Its gout drug Dotinurad is a once-daily oral inhibitor of urate transporter 1, designed to help the kidneys excrete uric acid. Excess uric acid can lead to the formation of crystals in the joints, causing the painful inflammation associated with gout. The drug's molecule is already approved in several Asian markets.
